A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

Portada

Imagen en miniatura
A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesi.pdf

Citas bibliográficas

Gestores Bibliográficos

Mendeley

Indexadores

Google
Microsoft Academic

Código QR

QR

LA Referencia Stats